As of July 14, 2026, Editas Medicine, Inc. (EDIT) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Editas Medicine, Inc. has a market capitalization of $530.98M, 97.91M shares outstanding, 209 institutional holders tracked. Key dilution vectors include 23.1K outstanding warrants, approximately 10 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
10%
💰 Capital Raise
15%
• Under 12 months cash (10mo)
🔄 Reverse Split
10%
• 10 months cash with weak price
💹 Market Data
Market Cap$530.98M
Shares Outstanding97.91M
Float97.73M
Cash$123.65M
Debt$54.68M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 23.4% shares (2026Q1 vs prior)
209 institutional holders · 64.52M shares
#1
BlackRock, Inc.
9.26M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
8.41M shares
#3
RENAISSANCE TECHNOLOGIES LLC
3.97M shares
📉 Short Interest
Short Interest22.47M
Days to Cover7.2
% of Float23.0%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jul 07, 2026
4
INSIDER TRANSACTION
Mar 04, 2026
4
INSIDER TRANSACTION
Mar 04, 2026
4
INSIDER TRANSACTION
Mar 04, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for EDIT Shareholders
Editas Medicine, Inc. (EDIT) has a DilutionScore of 47/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.
Cash runway is a key watch item: EDIT has approximately 10 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.
DilutionWatch tracks over 25 SEC filing types for EDIT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for EDIT alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track EDIT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EDIT — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for EDIT
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.